Guru Ownership Trend
Guru Analysis for Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. (SMMT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $30.32 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $15.72 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 9.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Summit Therapeutics Inc. (SMMT)
Major holders include Steven Cohen ($14.87 M), Cliff Asness ($8.11 M), Paul Tudor Jones ($7.3 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.73 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $15.72 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited SMMT. The total reported sell value was $722,300.11.
Yes, 1 managers opened new positions in SMMT, and 1 increased their existing holdings. The total reported buy value was $16.44 M.